A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3417
Last updated 2014-03-13
Summary
The study will evaluate a health services intervention to increase uptake of adolescent vaccines (HPV, Tdap, meningococcal conjugate, and influenza) among students enrolled in five school health centers by improving the consent process for parents.
Conditions
- Immunization Program
- School Health Services
- HPV Vaccines
Interventions
- BEHAVIORAL
-
Modified Vaccine Consent Form
Packet of written immunization materials for parents and students which includes the following: 1. Cover letter 2. Vaccine promotional flyer 3. Vaccine information sheets (one for adolescent vaccination and one for other vaccination) 4. Improved consent form 5. Note advertising a lottery for free movie tickets for returning the consent form 6. Self-addressed stamped envelope
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Noel T Brewer, PhD · University of North Carolina Chapel Hill, Department of Health Behavior and Health Education
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-09-30
- Primary Completion
- 2012-02-29
- Completion
- 2012-02-29
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
NCT00329901 ·Status: COMPLETED ·Phase: PHASE3
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 ·Status: COMPLETED ·Phase: NA
-
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 ·Status: COMPLETED
-
An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine Booster
NCT00870350 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of BCG on TDaP-IPV Vaccination
NCT02771782 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
NCT00325130 ·Status: COMPLETED ·Phase: PHASE3
-
Vouchers to Promote Tdap Vaccination
NCT01860378 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine
NCT00304265 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004799 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adolescent Immunization Recall Systems
NCT01390363 ·Status: COMPLETED ·Phase: NA
-
Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
NCT00263679 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age
NCT01346293 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding Typhoid Disease After Vaccination
NCT01405521 ·Status: COMPLETED ·Phase: PHASE2